Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

High growth rate of pancreatic ductal adenocarcinoma in CDKN2A-p16-Leiden mutation carriers.

Ibrahim IS, Wasser MNJM, Wu Y, Inderson A, De Vos Tot Nederveen Cappel WH, Morreau H, Hes FJ, Veenendaal RA, Putter H, Feshtali S, van Mil AM, Gruis NA, Tollenaar RAEM, Bergman W, Bonsing BA, Vasen HFA.

Cancer Prev Res (Phila). 2018 Jul 10. pii: canprevres.0035.2018. doi: 10.1158/1940-6207.CAPR-18-0035. [Epub ahead of print]

PMID:
29991580
2.

EUS-guided radiofrequency ablation for a left adrenal oligometastasis of an esophageal adenocarcinoma.

Inderson A, Slingerland M, Farina Sarasqueta A, de Steur WO, Boonstra JJ.

VideoGIE. 2018 Apr 12;3(5):159-161. doi: 10.1016/j.vgie.2018.03.001. eCollection 2018 May. No abstract available.

3.

Risk of multiple pancreatic cancers in CDKN2A-p16-Leiden mutation carriers.

Ibrahim I, Sibinga Mulder BG, Bonsing B, Morreau H, Farina Sarasqueta A, Inderson A, Luelmo S, Feshtali S, Potjer TP, de Vos Tot Nederveen Cappel W, Wasser M, Vasen HFA.

Eur J Hum Genet. 2018 May 16. doi: 10.1038/s41431-018-0170-y. [Epub ahead of print]

PMID:
29769629
4.

Diagnostic value of targeted next-generation sequencing in patients with suspected pancreatic or periampullary cancer.

Sibinga Mulder BG, Mieog JSD, Farina Sarasqueta A, Handgraaf HJ, Vasen HFA, Swijnenburg RJ, Luelmo SAC, Feshtali S, Inderson A, Vahrmeijer AL, Bonsing BA, Wezel TV, Morreau H.

J Clin Pathol. 2018 Mar;71(3):246-252. doi: 10.1136/jclinpath-2017-204607. Epub 2017 Aug 3.

PMID:
28775172
5.

Safety of Anti-TNF Treatment in Liver Transplant Recipients: A Systematic Review and Meta-analysis.

Westerouen van Meeteren MJ, Hayee B, Inderson A, van der Meulen AE, Altwegg R, van Hoek B, Pageaux GP, Stijnen T, Stein D, Maljaars PWJ.

J Crohns Colitis. 2017 Sep 1;11(9):1146-1151. doi: 10.1093/ecco-jcc/jjx057. Review.

PMID:
28482085
6.

Toward optical guidance during endoscopic ultrasound-guided fine needle aspirations of pancreatic masses using single fiber reflectance spectroscopy: a feasibility study.

Stegehuis PL, Boogerd LS, Inderson A, Veenendaal RA, van Gerven P, Bonsing BA, Sven Mieog J, Amelink A, Veselic M, Morreau H, van de Velde CJ, Lelieveldt BP, Dijkstra J, Robinson DJ, Vahrmeijer AL.

J Biomed Opt. 2017 Feb 1;22(2):24001. doi: 10.1117/1.JBO.22.2.024001.

PMID:
28170030
7.

Real-world experience with daclatasvir plus sofosbuvir ± ribavirin for post-liver transplant HCV recurrence and severe liver disease.

Herzer K, Welzel TM, Spengler U, Hinrichsen H, Klinker H, Berg T, Ferenci P, Peck-Radosavljevic M, Inderson A, Zhao Y, Jimenez-Exposito MJ, Zeuzem S.

Transpl Int. 2017 Mar;30(3):243-255. doi: 10.1111/tri.12910.

8.

Targeted next-generation sequencing of FNA-derived DNA in pancreatic cancer.

Sibinga Mulder BG, Mieog JS, Handgraaf HJ, Farina Sarasqueta A, Vasen HF, Potjer TP, Swijnenburg RJ, Luelmo SA, Feshtali S, Inderson A, Vahrmeijer AL, Bonsing BA, van Wezel T, Morreau H.

J Clin Pathol. 2017 Feb;70(2):174-178. doi: 10.1136/jclinpath-2016-203928. Epub 2016 Sep 26.

PMID:
27672215
9.

Dilemmas in the management of screen-detected lesions in patients at high risk for pancreatic cancer.

Ibrahim IS, Bonsing BA, Swijnenburg RJ, Welling L, Veenendaal RA, Wasser MN, Morreau H, Inderson A, Vasen HF.

Fam Cancer. 2017 Jan;16(1):111-115. doi: 10.1007/s10689-016-9915-3.

10.

Response: Limited sampling strategies for once daily tacrolimus exposure monitoring.

Moes DJ, Swen JJ, van der Bent SA, van der Straaten T, Inderson A, Olofsen E, Verspaget HW, Guchelaar HJ, den Hartigh J, van Hoek B.

Eur J Clin Pharmacol. 2016 Jun;72(6):775-6. doi: 10.1007/s00228-016-2036-y. Epub 2016 Mar 2. No abstract available.

PMID:
26931555
11.

Population pharmacokinetics and pharmacogenetics of once daily tacrolimus formulation in stable liver transplant recipients.

Moes DJ, van der Bent SA, Swen JJ, van der Straaten T, Inderson A, Olofsen E, Verspaget HW, Guchelaar HJ, den Hartigh J, van Hoek B.

Eur J Clin Pharmacol. 2016 Feb;72(2):163-74. doi: 10.1007/s00228-015-1963-3. Epub 2015 Oct 31.

12.

High peak alanine aminotransferase determines extra risk for nonanastomotic biliary strictures after liver transplantation with donation after circulatory death.

den Dulk AC, Sebib Korkmaz K, de Rooij BJ, Sutton ME, Braat AE, Inderson A, Dubbeld J, Verspaget HW, Porte RJ, van Hoek B.

Transpl Int. 2015 Apr;28(4):492-501. doi: 10.1111/tri.12524. Epub 2015 Jan 30.

13.

Limited sampling model for advanced mycophenolic acid therapeutic drug monitoring after liver transplantation.

Langers P, Press RR, Inderson A, Cremers SC, den Hartigh J, Baranski AG, van Hoek B.

Ther Drug Monit. 2014 Apr;36(2):141-7. doi: 10.1097/FTD.0b013e3182a37a1e.

PMID:
24081208
14.

Lipid profile and carotid intima-media thickness in a prospective cohort of very preterm subjects at age 19 years: effects of early growth and current body composition.

Finken MJ, Inderson A, Van Montfoort N, Keijzer-Veen MG, van Weert AW, Carfil N, Frölich M, Hille ET, Romijn JA, Dekker FW, Wit JM; Dutch POPS-19 Collaborative Study Group.

Pediatr Res. 2006 Apr;59(4 Pt 1):604-9.

PMID:
16549538

Supplemental Content

Loading ...
Support Center